Skip to content
Screener

Amneal Pharmaceuticals, Inc. AMRX Common Stock

Common Stock at other companies

McKesson logo
McKessonMCK
800M0.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$3K+50.0%
Cencora logo
CencoraCOR
$2.98M—
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$0-100%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
200M0.0%
AbbVie logo
AbbVieABBV
$18M0.0%

Other financials

Income statement

See full
Revenue$796.2M+9.9%
Gross profit$334.5M+16.9%
Operating income$129.8M+16.5%
Net income$57.7M+157%
EPS (diluted)$0.18+157%

Balance sheet

See full
Cash & equivalents$127.6M+78.4%
Total debt$2.6B+18.0%
Total equity$33.0M+129%
Total assets$3.8B+10.3%

Cash flow

See full
Operating cash flow-$21.2M-125%
CapEx$30.7M+34.5%
Free cash flow-$51.9M-185%

Valuation

See full
Market cap$5.77B+129%
Enterprise value$8.21B+77.4%
P/E36.7×-711×
P/S1.9×+1.0×

Profitability

See full
Gross margin39.3%+1.7pp
Operating margin14.6%+1.4pp
Net margin5%+4.9pp
FCF margin4.1%-5.8pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity77.8×—
Current ratio2.2×+0.8×

Where this comes from

Reported directly by Amneal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2018. Open the filing →

Filed
May 15, 2018
Fiscal quarter
Q1 FY2018
Calendar quarter
Q1 2018
Accession
0001723128-18-000013

FAQ

What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).